IDEAS home Printed from https://ideas.repec.org/a/pkp/joudig/v7y2020i1p1-6id2431.html
   My bibliography  Save this article

The Outcome and Hepatic Function of an Extended Category II Treatment in a HIV-Seronegative Suspected Extensively Drug-Resistant TB Patient

Author

Listed:
  • Ato Kwamena Tetteh
  • Edward Agyarko
  • Joseph Otchere
  • Langbong Bimi
  • Irene Ayi

Abstract

A 25 year old HIV- seronegative client was diagnosed with pulmonary tuberculosis and placed on Category I (CAT I) treatment. After two months, acid fast bacilli (AFB) persisted in sputum. Rifampicin (Rif) resistance was detected with the GeneXpert MTB-Rif Assay® (Xpert; Cepheid, Sunnyvale, CA, USA), leading to a change in treatment to CAT II after completing CAT I in the third month. Continuous detection of Rif resistant species and persisting ‘Scanty’ results (1-9 AFB found in 100 microscopic fields) from sputum smear microscopy (SSM) after one (1) year was suggestive of treatment failure to CAT II [possible extensively drug-resistant (XDR) species]. Category II treatment was continued for the next eight months as we anticipated the arrival of XDR medicines. Before commencement of XDR medication, SSM and GeneXpert were repeated. The SSM result was negative (no AFB seen), while Rif resistance persisted. The controversy was eventually clarified with the Bactec Mycobacteria Growth Indicator Tube (MGIT) liquid culture, which indicated no growth for M. tuberculosis. Since the rapid molecular GeneXpert will persistently detect Rif resistance even after months of treatment, we support the use of MGIT to confirm when treatment should be halted. This case study also showed tolerance to prolonged treatment with CAT I and II drugs and confirms evidence in existing literature.

Suggested Citation

  • Ato Kwamena Tetteh & Edward Agyarko & Joseph Otchere & Langbong Bimi & Irene Ayi, 2020. "The Outcome and Hepatic Function of an Extended Category II Treatment in a HIV-Seronegative Suspected Extensively Drug-Resistant TB Patient," Journal of Diagnostics, Conscientia Beam, vol. 7(1), pages 1-6.
    • Handle: RePEc:pkp:joudig:v:7:y:2020:i:1:p:1-6:id:2431
    as

    Download full text from publisher

    File URL: https://archive.conscientiabeam.com/index.php/98/article/view/2431/3694
    Download Restriction: no
    File URL: https://archive.conscientiabeam.com/index.php/98/article/view/2431/5525
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pkp:joudig:v:7:y:2020:i:1:p:1-6:id:2431. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Dim Michael (email available below). General contact details of provider: https://archive.conscientiabeam.com/index.php/98/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.